We have a new client, new assignment. A Texas based Pharma has appointed Aagami for divesting 2 oncology assets.The client, after acquiring a nov...
Published : 13 Aug 2020
Read MoreA Silicon Valley based company has appointed Aagami to support their investment needs. The client is developing and commercializing a ma...
Published : 24 Jul 2020
Read MoreAn Oakland, California based medical technology start-up developing the portable single-sided MRI, has appointed Aagami for supporting their need for ...
Published : 23 Jun 2020
Read MoreA Japanese company has chosen Aagami to partner with marketing and selling companies from the US, India and across the world for their on the market p...
Published : 02 Jun 2020
Read MoreAagami has received an assignment from a French company developing a natural tobacco leaf extracted drug for smoking cessation. Only 2 injections for ...
Published : 19 May 2020
Read MoreWe all know that Covid-19 has taken a toll on humanity, spreading across almost all countries, infecting more than 225,000 people globally, and taking...
Published : 19 Mar 2020
Read MoreAagami has secured an innovative startup client to support their investment and partnering initiatives. Aagami’s extensive knowledge and networ...
Published : 09 Mar 2020
Read MoreAn Israeli client, has given a new assignment to Aagami, for partnering their Drug-device combination to prevent Hangover and Asian Flush based on FDA...
Published : 06 Jan 2020
Read MoreAagami is proud to announce that it will be representing multiple clients with respect to the partnering of their assets and technologies, during JPM ...
Published : 09 Dec 2019
Read MoreAagami has now increased its focus in IP monetization and offers integrated IP Research/ Licensing/Sale solutions to global clientele. For this i...
Published : 04 Nov 2019
Read More